skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: In your recent answer regarding 3 growth stocks in a TFSA you chose KXS,PBH,SIS. I wonder if you could elaborate on your thoughts about how you chose these. PKI, as an example seems, to have a good growth profile over the next 2 years and pays a nice dividend. Why not choose it.
I used the numbers provided by RBC Direct Investing below.
Thanks Mike

kxs Crnt P/e 1Yr Ern Gwth 2nd Yr Divi
KXS 121 37% 18% 0
PBH 35 42% 31% 1.61%
SIS 40 22% 50% 2.62%
PKI 65 37% 66% 4.5%
Read Answer Asked by michael on September 29, 2017
Q: I'm down approx. 10% on EFN. Should I stay patient with it or would you recommend another position from your coverage universe that has better potential to make up for this loss? I already own SYZ, SJ,SHOP, MG, CSU, CGX, KXS,PBH, SIS,FSZ,GSY,NFI, CCL, MX, OTEX,PKI,PHO, TOY. Timeframe of 2-3 years. thx
Read Answer Asked by Chris on September 29, 2017
Q: Photon Control (PHO) is up strongly today on stronger than normal volume. I couldn't find any specific statements from the company linked to this, but yesterday Lam Research, a semiconductor equipment maker that uses PHO's products, announced results that were well received by the market. Is this driving the sentiment about PHO?

Thanks to the 5i team for informative and balanced insight.
Read Answer Asked by Steve on September 29, 2017
Q: I own CFP,WEF,and WFT. All three are down 2 or more % points this morning. Would you read anything into this drop such as NAFTA or otherwise? With thanks, Bill
Read Answer Asked by William J on September 29, 2017
Q: Hello 5i team,
My holdings in the technology sector represent 23% of my portfolio; they consist of CLS, CSU, DSG, ENGH, GIB.A, KXS, OTEX, PHO and SHOP. I wish to shed at least 2 of them; which would you suggest?
Thanks,
Antoine
Read Answer Asked by Antoine on September 29, 2017
Q: PVG has been a short target for a long time, perhaps a hangover from the Farqu-up period. In the last couple of weeks shorts have increased a further 260,000 to 31% of the issued stock and equal to 15 days of average trading. I like this gold producer. What am I overlooking? Phil

Short Interest (Shares Short)
26,041,200
Short Interest Ratio (Days To Cover)
15.6
Short Percent of Float
31.01 %
Short % Increase / Decrease
1 %
Short Interest (Shares Short) - Prior
25,708,600
Shares Float
83,975,800
Read Answer Asked by thomas philip on September 29, 2017
Q: I have acquired shares in several new companies over time, as a result of spin-offs. Sometimes these are terrific, such as BIP.UN. I'd like to either add to some of these 'stub' positions or sell them to keep my number of stocks manageable. Can you please divide these four companies between (in your opinion) 'worth keeping and adding to', or 'sell to redeploy the proceeds elsewhere'. The four are Trisura (TSU), Brookfield Business Partners (BBU.UN), Express Scripts (ESRX) and Brighthouse (BHF), recently spun off from MetLife. Thank you!
Read Answer Asked by James on September 29, 2017
Q: Hello 5i,
David Burman in the G&M today suggests selling Couche-Tard if Metro sells its shares in it. With the potential Metro/Jean Coutu merger, what if any action, and when, should investors take with their Couche-Tard holdings? For context, I own Couche-Tard, Loblaw and Northwest Company in consumer staples.
Thank you, Michael
Read Answer Asked by Michael on September 29, 2017
Q: Good morning,
Bearish article on Couche Tard in the Globd this morning. Berman cites Metro would dump its significant stake in ATD in order to find the Jean Coutu acquisition. Je suggests exiting the stock. I just I Have held couche tard for the better part of 18 months and stock only drifting lower.
Please comment. Is couche tard still viewed as a high conviction stock by 5i?
Thank you
Karim
Read Answer Asked by Karim on September 29, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!